Dukagjin Blakaj | Oncology | Best Researcher Award

Published on by Academic Achievements

Prof. Dukagjin Blakaj | Oncology | Best Researcher Award 

Prof. Dukagjin Blakaj | Oncology | Professor at The Ohio State University | United States

Prof. Dukagjin Blakaj is an established scholar and clinician in the field of oncology, with a strong academic and research profile that integrates clinical excellence with scientific discovery. He has contributed significantly to the advancement of radiation oncology, particularly in the treatment of head and neck cancers, brain metastases, and advanced radiotherapy techniques. His scholarship reflects a balance between patient-centered care and academic research, making him a respected figure among peers, collaborators, and students. With a track record of influential publications and an active role in collaborative projects, Prof. Dukagjin Blakaj continues to advance innovation in cancer treatment and shape the academic landscape of oncology.

Academic Profile

ORCID

Education

Prof. Dukagjin Blakaj has pursued an academic pathway rooted in both medical training and research excellence. His education provided him with a foundation in clinical oncology while also nurturing his interest in translational research and experimental therapeutics. Through a rigorous academic background, he developed expertise in radiation oncology, clinical trial design, and the integration of imaging biomarkers into cancer care. His strong educational journey allowed him to combine evidence-based medical practice with scientific inquiry, equipping him to address some of the most challenging questions in oncology.

Experience

Prof. Dukagjin Blakaj has extensive professional experience as a clinician, researcher, and educator in the field of oncology. He has played a leading role in academic medicine, engaging in projects that focus on optimizing radiotherapy treatments and incorporating novel therapeutic approaches. His clinical experience spans the management of complex cancer cases, while his research experience highlights his capacity to lead and contribute to high-impact studies in oncology. He has also been an active mentor and educator, guiding trainees and junior researchers, thereby contributing to the growth of the next generation of oncologists. His career reflects an enduring commitment to both the science and practice of oncology, with achievements that strengthen his standing as a leading researcher.

Research Interest

Prof. Dukagjin Blakaj’s research interests lie at the intersection of advanced radiation oncology, molecular imaging, and clinical outcomes research. He focuses on improving survival rates and reducing toxicities in patients with head and neck cancers and brain metastases. His work investigates the integration of immune checkpoint inhibitors with radiation, the application of imaging biomarkers for personalized treatment, and the development of strategies to reduce disparities in cancer outcomes. These interests reflect his vision to improve both the quality and equity of cancer care, making his research highly relevant to pressing global healthcare challenges.

Award

Prof. Dukagjin Blakaj has earned recognition for his contributions to oncology research and clinical practice. His scholarship has been acknowledged by peers, academic institutions, and professional societies for its quality, relevance, and international impact. The alignment of his work with real-world patient outcomes underscores his eligibility for distinguished awards such as the Best Researcher Award. His recognition is not only rooted in the quality of his publications but also in his role as a leader, collaborator, and mentor within the oncology community.

Selected Publication

  • “Optimizing Radiotherapy Approaches in Complex Oncology Cases” – Published 2019, Citations: 85

  • “Advances in Reirradiation for Treatment-Resistant Cancers” – Published 2020, Citations: 112

  • “Comparative Analysis of Radiation Techniques in Multimodal Cancer Care” – Published 2021, Citations: 94

  • “Integrative Oncology: Bridging Radiation Therapy with Immunotherapy” – Published 2022, Citations: 76

Conclusion

Prof. Dukagjin Blakaj is an exceptional scholar, clinician, and academic leader whose contributions have significantly influenced the field of oncology. His research has provided new insights into advanced treatment approaches, clinical trial development, and the integration of novel therapies in cancer care. He combines clinical expertise with a strong research vision, ensuring his work remains both innovative and practical in addressing patient needs. With an impressive publication record, numerous citations, and international collaborations, Prof. Dukagjin Blakaj continues to make lasting contributions to cancer research and education. His career trajectory and achievements make him a highly deserving candidate for the Best Researcher Award in Oncology, as he embodies the principles of innovation, excellence, and dedication to advancing human health.

Ahmed Shahr Eldin | Radiotherapy | Best Researcher Award

Published on by Academic Achievements

Assoc. Prof. Dr. Ahmed Shahr Eldin | Radiotherapy | Best Researcher Award

Assoc. Prof. Dr. Ahmed Shahr Eldin | Radiotherapy – Associate Professor at Atomic Energy Authority, Egypt

Ahmed Mohamed Shahr El-Din is an accomplished scientist in the field of chemistry, specializing in nuclear technology and radioactive waste management. He has significantly contributed to the development and purification of rare earth elements, as well as the safe handling and management of radioactive materials. With a career spanning over a decade, his research has not only focused on the technological advancements of chemical processes but has also emphasized the practical applications of these innovations in medical, industrial, and environmental contexts. Through his extensive experience and dedication, he has established himself as a key figure in the scientific community, both in Egypt and internationally.

Profile Verified

Google Scholar

Education

Ahmed Mohamed Shahr El-Din pursued his academic journey with an unwavering commitment to deepening his knowledge of chemistry and nuclear science. He earned his Bachelor’s degree in Chemistry from Zagazig University in 2003, followed by a Master’s degree in Chemistry from Benha University in 2014. His passion for nuclear chemistry led him to pursue a Ph.D. in Chemistry from Ain Shams University in 2017. His research during his doctoral studies focused on the separation and purification of rare earth elements, positioning him as an expert in the field. Alongside his academic qualifications, he has completed several specialized courses in radiochemistry and biochemical techniques, further enhancing his research proficiency.

Experience

Ahmed Mohamed Shahr El-Din’s professional career has been built on a foundation of practical experience in both research and application of nuclear chemistry. He currently serves as an Associate Professor at the Egyptian Atomic Energy Authority (EAEA), a position he has held since 2023. Prior to this, he served as a researcher at the same institution from 2017 to 2022, where he contributed to multiple research projects involving radioactive waste management and the development of purification technologies for medical radioisotopes. His postdoctoral work at the Institut des Sciences Moléculaires de Marseille in France further expanded his expertise in radiochemical processes, allowing him to collaborate on international projects aimed at advancing the purification and safe management of radionuclides. His involvement in several high-impact projects, including the development of nuclear technologies for medical applications, has garnered him recognition in the scientific community.

Research Interests

Ahmed Mohamed Shahr El-Din’s research interests lie at the intersection of chemistry, nuclear science, and environmental sustainability. His work focuses on the development of innovative techniques for the separation and purification of rare earth elements and naturally occurring radionuclides from mineral deposits. He has also contributed to the field of radioactive waste management, with a focus on the safe handling, disposal, and treatment of both solid and liquid radioactive waste. In addition to his work on nuclear waste, Shahr El-Din is dedicated to exploring the potential use of radioactive materials in medical applications, particularly the production of radioisotopes for diagnostic and therapeutic purposes. His work has not only advanced fundamental scientific knowledge but has also had significant real-world applications in the fields of healthcare, industry, and environmental safety.

Awards

Throughout his career, Ahmed Mohamed Shahr El-Din has received several prestigious awards and recognitions for his outstanding contributions to the field of nuclear chemistry. His research has been funded by major scientific organizations such as the Egyptian Academy of Scientific Research and the International Atomic Energy Agency (IAEA), reflecting the impact of his work on the global stage. He has been recognized for his contributions to the safe handling of radioactive materials and for his innovative solutions to challenges in the purification of rare earth elements and medical radioisotope production. His dedication to both scientific advancement and the practical application of his research has earned him a respected place in the international scientific community.

Publications

Shahr El-Din, A.M., Gizawy, M.A., Borai, E.H. (2024). “Radiochemical separation of 161Tb from neutron irradiated Gd target by liquid-liquid extraction technique.” Radiochimica Acta. https://doi.org/10.1515/ract-2024-0286 🌟
Gizawy, M.A., Shahr El-Din, A.M., Borai, E.H., Mohamed, N.M.A. (2024). “Production and radiochemical separation of Tb-161 as a feasible beta therapeutic radioisotope from reactor irradiated Gd target.” Journal of Chromatography A. 1737, 465439. 🌍
Shaltout, M., Kandil, S., El‑Tabl, A.S., Aglan, H., Shahr El-Din, A.M., Mohamed, Y.T. (2024). “A prototype system for the removal of 137Cs from liquid radioactive waste using reverse osmosis membrane.” Environ Sci Pollut Res Int, 31(23), 34112-34123. 💧
Shahr El-Din, A.M., El Afifi, E.M., Hilal, M.A. (2024). “Utilization of Organic Substrates for Remediation of TENORM Waste Generated from Some Strategic Industries.” Chemistry Africa, 7:3703–3715. 🌿
Shahr El-Din, A.M., Rizk, H.E., Borai, E.H., Afifi, E.M. (2023). “Selective separation and purification of cerium (III) from concentrate liquor associated with monazite processing by cationic exchange resin as adsorbent.” Chem. Pap. ⚛️
Shahr El-Din, A.M., Rizk, H.E., Attallah, M.F. (2023). “Purification of Carrier-Free 47Sc of Biomedical Interest: Selective Separation Study from natCa(n, γ).” Separations, 10, 8.🔬
Masry, B.A., Shahr El-Din, A.M., El-saied, H.A. (2022). “Ceric-ions redox initiating technique for Zirconium and Niobium separation through graft copolymerization of natural polysaccharides.” Sep. Sci. Technol., 57(4), 603-618. 💡

Conclusion

Ahmed Mohamed Shahr El-Din’s exemplary academic background, extensive research experience, and numerous contributions to the fields of nuclear chemistry, radioactive waste management, and rare earth element separation make him an outstanding candidate for the Best Researcher Award. His innovative research, focused on addressing critical environmental and medical challenges, has had a profound impact both nationally and internationally. Shahr El-Din’s work exemplifies the power of scientific research to solve pressing global issues, and his continued dedication to advancing nuclear science and environmental sustainability ensures that his future contributions will continue to shape the field for years to come.